SK11262000A3 - Deriváty dihydroxyhexánovej kyseliny a farmaceutický prostriedok,ktorý ich obsahuje - Google Patents
Deriváty dihydroxyhexánovej kyseliny a farmaceutický prostriedok,ktorý ich obsahuje Download PDFInfo
- Publication number
- SK11262000A3 SK11262000A3 SK1126-2000A SK11262000A SK11262000A3 SK 11262000 A3 SK11262000 A3 SK 11262000A3 SK 11262000 A SK11262000 A SK 11262000A SK 11262000 A3 SK11262000 A3 SK 11262000A3
- Authority
- SK
- Slovakia
- Prior art keywords
- diseases
- conditions
- carboxylic acid
- methyl
- dihydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
- C07D241/52—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Transplantation (AREA)
- Urology & Nephrology (AREA)
- AIDS & HIV (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7380198P | 1998-02-05 | 1998-02-05 | |
| PCT/IB1999/000067 WO1999040061A2 (en) | 1998-02-05 | 1999-01-18 | Novel dihydroxyhexanoic acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK11262000A3 true SK11262000A3 (sk) | 2001-01-18 |
Family
ID=22115885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1126-2000A SK11262000A3 (sk) | 1998-02-05 | 1999-01-18 | Deriváty dihydroxyhexánovej kyseliny a farmaceutický prostriedok,ktorý ich obsahuje |
Country Status (37)
| Country | Link |
|---|---|
| EP (1) | EP1051405B1 (hu) |
| JP (1) | JP3693916B2 (hu) |
| KR (1) | KR100385529B1 (hu) |
| CN (1) | CN1177834C (hu) |
| AP (1) | AP992A (hu) |
| AR (1) | AR016175A1 (hu) |
| AT (1) | ATE337307T1 (hu) |
| AU (1) | AU752407B2 (hu) |
| BG (1) | BG104726A (hu) |
| BR (1) | BR9907655A (hu) |
| CA (1) | CA2320388C (hu) |
| DE (1) | DE69932920T2 (hu) |
| DZ (1) | DZ2717A1 (hu) |
| EA (1) | EA003137B1 (hu) |
| ES (1) | ES2268847T3 (hu) |
| GT (1) | GT199900011A (hu) |
| HK (1) | HK1034969A1 (hu) |
| HR (1) | HRP20000529B1 (hu) |
| HU (1) | HUP0100832A3 (hu) |
| IL (1) | IL137330A0 (hu) |
| IS (1) | IS5562A (hu) |
| MA (1) | MA26603A1 (hu) |
| MY (1) | MY133125A (hu) |
| NO (1) | NO20003965D0 (hu) |
| NZ (1) | NZ505724A (hu) |
| OA (1) | OA11448A (hu) |
| PA (1) | PA8467301A1 (hu) |
| PE (1) | PE20000243A1 (hu) |
| PL (1) | PL342817A1 (hu) |
| SK (1) | SK11262000A3 (hu) |
| TN (1) | TNSN99013A1 (hu) |
| TR (1) | TR200002248T2 (hu) |
| TW (1) | TW470744B (hu) |
| UA (1) | UA57824C2 (hu) |
| WO (1) | WO1999040061A2 (hu) |
| YU (1) | YU47100A (hu) |
| ZA (1) | ZA99873B (hu) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2360672A1 (en) * | 1999-01-29 | 2000-08-03 | Wayne W. Hancock | Methods for preventing graft rejection and ischemia-reperfusion injury |
| PL205059B1 (pl) * | 1999-08-20 | 2010-03-31 | Dow Agrosciences Llc | Heterocykliczny amid aromatyczny, jego kompozycja grzybobójcza oraz sposób zwalczania lub zapobiegania zakażeniom grzybami |
| SK10882002A3 (sk) | 2000-02-04 | 2003-10-07 | Pfizer Products Inc. | Heterocyklické amidové deriváty |
| EP1498417A1 (en) * | 2000-02-04 | 2005-01-19 | Pfizer Products Inc. | Heterocyclic amide derivatives |
| US6740636B2 (en) | 2000-07-31 | 2004-05-25 | Schering Aktiengesellschaft | Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection |
| US6746856B2 (en) | 2000-08-09 | 2004-06-08 | Pfizer Inc. | Microbial conversion of bicyclic heteroaromatic compounds |
| EP1269994A3 (en) * | 2001-06-22 | 2003-02-12 | Pfizer Products Inc. | Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
| NZ529490A (en) | 2001-06-22 | 2005-08-26 | Pfizer Prod Inc | Pharmaceutical compositions of adsorbates of amorphous drug |
| JP2004534812A (ja) | 2001-06-22 | 2004-11-18 | ファイザー・プロダクツ・インク | 薬物および中性ポリマーの分散物の医薬組成物 |
| DE10152351B4 (de) * | 2001-10-18 | 2005-09-22 | Schering Ag | Feste Arzneimittelformulierung für ein Piperazinharnstoffderivat |
| WO2003063833A1 (en) | 2002-02-01 | 2003-08-07 | Pfizer Products Inc. | Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials |
| BR0309932A (pt) * | 2002-05-14 | 2005-02-09 | Pfizer Prod Inc | Métodos para a fabricação de derivados de diidro-furan-2-ona |
| CN1653056A (zh) * | 2002-05-14 | 2005-08-10 | 辉瑞产品公司 | 二羟基己酸衍生物、它们的中间体和制备方法 |
| WO2004014875A1 (en) * | 2002-08-12 | 2004-02-19 | Pfizer Products Inc. | Crystal forms of quinoxaline-2-carboxylic acid [4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl]-amide |
| PT1530457E (pt) | 2002-08-12 | 2009-11-06 | Bend Res Inc | Composições farmacêuticas de fármacos na forma semi-ordenada e de polímeros |
| US20040097554A1 (en) * | 2002-10-30 | 2004-05-20 | Pfizer Inc | Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents |
| US20040087571A1 (en) * | 2002-10-30 | 2004-05-06 | Pfizer Inc | Methods of using CCR1 antagonists as immunomodulatory agents |
| WO2005011635A2 (en) | 2003-08-04 | 2005-02-10 | Pfizer Products Inc. | Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4923864A (en) * | 1987-12-15 | 1990-05-08 | Pfizer Inc. | Certain heterocyclic-hexanamides useful for treating hypertension |
| ATE220661T1 (de) * | 1994-10-19 | 2002-08-15 | Novartis Erfind Verwalt Gmbh | Antivirale ether von aspartat-protease-substrat- isosteren |
| DE19708106A1 (de) * | 1997-02-28 | 1998-09-03 | Bosch Gmbh Robert | Einrichtung und Verfahren zur Information über Verkehrsstörungen |
-
1999
- 1999-01-18 SK SK1126-2000A patent/SK11262000A3/sk unknown
- 1999-01-18 ES ES99900098T patent/ES2268847T3/es not_active Expired - Lifetime
- 1999-01-18 JP JP2000530493A patent/JP3693916B2/ja not_active Expired - Lifetime
- 1999-01-18 NZ NZ505724A patent/NZ505724A/xx unknown
- 1999-01-18 CA CA002320388A patent/CA2320388C/en not_active Expired - Fee Related
- 1999-01-18 BR BR9907655-1A patent/BR9907655A/pt not_active Application Discontinuation
- 1999-01-18 YU YU47100A patent/YU47100A/sh unknown
- 1999-01-18 DE DE69932920T patent/DE69932920T2/de not_active Expired - Lifetime
- 1999-01-18 CN CNB998027138A patent/CN1177834C/zh not_active Expired - Fee Related
- 1999-01-18 HU HU0100832A patent/HUP0100832A3/hu unknown
- 1999-01-18 PA PA19998467301A patent/PA8467301A1/es unknown
- 1999-01-18 KR KR10-2000-7008561A patent/KR100385529B1/ko not_active IP Right Cessation
- 1999-01-18 IL IL13733099A patent/IL137330A0/xx unknown
- 1999-01-18 TR TR2000/02248T patent/TR200002248T2/xx unknown
- 1999-01-18 UA UA2000074534A patent/UA57824C2/uk unknown
- 1999-01-18 WO PCT/IB1999/000067 patent/WO1999040061A2/en active IP Right Grant
- 1999-01-18 AU AU17789/99A patent/AU752407B2/en not_active Ceased
- 1999-01-18 PL PL99342817A patent/PL342817A1/xx not_active Application Discontinuation
- 1999-01-18 EP EP99900098A patent/EP1051405B1/en not_active Expired - Lifetime
- 1999-01-18 EA EA200000741A patent/EA003137B1/ru not_active IP Right Cessation
- 1999-01-18 AT AT99900098T patent/ATE337307T1/de not_active IP Right Cessation
- 1999-01-27 GT GT199900011A patent/GT199900011A/es unknown
- 1999-02-01 PE PE1999000071A patent/PE20000243A1/es not_active Application Discontinuation
- 1999-02-01 TW TW088101505A patent/TW470744B/zh not_active IP Right Cessation
- 1999-02-03 TN TNTNSN99013A patent/TNSN99013A1/fr unknown
- 1999-02-03 MY MYPI99000363A patent/MY133125A/en unknown
- 1999-02-03 AR ARP990100443A patent/AR016175A1/es unknown
- 1999-02-03 MA MA25448A patent/MA26603A1/fr unknown
- 1999-02-03 DZ DZ990018A patent/DZ2717A1/xx active
- 1999-02-04 ZA ZA9900873A patent/ZA99873B/xx unknown
- 1999-02-04 AP APAP/P/1999/001457A patent/AP992A/en active
-
2000
- 2000-07-14 IS IS5562A patent/IS5562A/is unknown
- 2000-07-28 OA OA1200000214A patent/OA11448A/en unknown
- 2000-08-04 HR HR20000529 patent/HRP20000529B1/xx not_active IP Right Cessation
- 2000-08-04 NO NO20003965A patent/NO20003965D0/no not_active Application Discontinuation
- 2000-08-29 BG BG104726A patent/BG104726A/xx unknown
-
2001
- 2001-08-15 HK HK01105717A patent/HK1034969A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK11262000A3 (sk) | Deriváty dihydroxyhexánovej kyseliny a farmaceutický prostriedok,ktorý ich obsahuje | |
| US11236045B2 (en) | Substituted sulfoximine compounds | |
| JP6778114B2 (ja) | イミド系タンパク質分解モジュレーター及び関連する使用方法 | |
| JP6483666B2 (ja) | 選択的に置換されたキノリン化合物 | |
| EP0610743B1 (en) | Aminomethylene-peptides as immunosuppressants | |
| KR102083693B1 (ko) | Ccr9 길항제로써 피라졸-1-일 벤젠 술폰아미드 | |
| UA67735C2 (uk) | Похідні амідів гетероарил-гексанових кислот, фармацевтична композиція для лікування чи попередження розладів чи станів (варіанти) та спосіб лікування чи попередження розладів чи станів (варіанти) | |
| CA2086428A1 (en) | Immunosuppressive compounds | |
| SK1192002A3 (en) | Caspase inhibitors and uses thereof | |
| AU2007279256A1 (en) | Modulators of chemokine receptor activity, crystalline forms and process | |
| US20050282816A1 (en) | Pyrazinylmethyl lactam derivatives | |
| KR102335082B1 (ko) | 헤테로사이클릭 화합물 및 이의 용도 | |
| EP1140897A1 (en) | Protease inhibitors | |
| US6673801B1 (en) | Dihydroxyhexanoic acid derivatives | |
| JPH06271533A (ja) | 免疫抑制剤としての新規なアミノメチレン誘導体 | |
| CZ20002760A3 (cs) | Nové deriváty dihydroxyhexanové kyseliny a farmaceutický prostředek, který je obsahuje | |
| NZ523610A (en) | A method of treating inflammatory conditions in a non-human mammal comprising administration of dihydroxyhexanoic acid derivatives | |
| MXPA00007690A (en) | Novel dihydroxyhexanoic acid derivatives | |
| US10197557B2 (en) | Small molecules for endothelial cell activation | |
| US20180258135A1 (en) | Novel hdac inhibitors and methods of treatment using the same | |
| JPH05271187A (ja) | ピロリジン誘導体又はその薬学的に許容される塩 | |
| CZ9902904A3 (cs) | Deriváty amidů heteroarylhexanových kyselin, farmaceutické kompozice na jejich bázi a způsoby léčení nebo prevence |